51 related articles for article (PubMed ID: 17532961)
1. Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest.
Hickey EJ; You X; Kaimaktchiev V; Stenzel-Poore M; Ungerleider RM
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1588-96. PubMed ID: 17532961
[TBL] [Abstract][Full Text] [Related]
2. Effects of intraperitoneal injection of lipopolysaccharide-induced peripheral inflammation on dopamine neuron damage in rat midbrain.
Yang QY; Li XW; Yang R; Qin TY; Long H; Zhang SB; Zhang F
CNS Neurosci Ther; 2022 Oct; 28(10):1624-1636. PubMed ID: 35789066
[TBL] [Abstract][Full Text] [Related]
3. Low-dose lipopolysaccharide as an immune regulator for homeostasis maintenance in the central nervous system through transformation to neuroprotective microglia.
Mizobuchi H; Soma GI
Neural Regen Res; 2021 Oct; 16(10):1928-1934. PubMed ID: 33642362
[TBL] [Abstract][Full Text] [Related]
4. Peripheral immune tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation-related neurotoxicity.
Liu Y; Xie X; Xia LP; Lv H; Lou F; Ren Y; He ZY; Luo XG
J Neuroinflammation; 2017 Nov; 14(1):223. PubMed ID: 29145874
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic mechanisms following ischemic stroke.
Khoshnam SE; Winlow W; Farzaneh M; Farbood Y; Moghaddam HF
Neurol Sci; 2017 Jul; 38(7):1167-1186. PubMed ID: 28417216
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Development of a Prophylactic Neuroprotective Therapy for the Preventive Treatment of Anticipated Ischemia-Reperfusion Injury.
Bahjat FR; Alexander West G; Kohama SG; Glynn C; Urbanski HF; Hobbs TR; Earl E; Stevens SL; Stenzel-Poore MP
Transl Stroke Res; 2017 Aug; 8(4):322-333. PubMed ID: 28378315
[TBL] [Abstract][Full Text] [Related]
7. Rational modulation of the innate immune system for neuroprotection in ischemic stroke.
Amantea D; Micieli G; Tassorelli C; Cuartero MI; Ballesteros I; Certo M; Moro MA; Lizasoain I; Bagetta G
Front Neurosci; 2015; 9():147. PubMed ID: 25972779
[TBL] [Abstract][Full Text] [Related]
8. Function and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment.
Wang PF; Xiong XY; Chen J; Wang YC; Duan W; Yang QW
J Neuroinflammation; 2015 Apr; 12():80. PubMed ID: 25928750
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming the response to stroke by preconditioning.
Stevens SL; Vartanian KB; Stenzel-Poore MP
Stroke; 2014 Aug; 45(8):2527-31. PubMed ID: 24938838
[No Abstract] [Full Text] [Related]
10. Immune mechanisms in cerebral ischemic tolerance.
Garcia-Bonilla L; Benakis C; Moore J; Iadecola C; Anrather J
Front Neurosci; 2014; 8():44. PubMed ID: 24624056
[TBL] [Abstract][Full Text] [Related]
11. Targeting toll-like receptor signaling as a novel approach to prevent ocular infectious diseases.
Pandey RK; Yu FS; Kumar A
Indian J Med Res; 2013 Nov; 138(5):609-19. PubMed ID: 24434316
[TBL] [Abstract][Full Text] [Related]
12. Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.
Stetler RA; Leak RK; Gan Y; Li P; Zhang F; Hu X; Jing Z; Chen J; Zigmond MJ; Gao Y
Prog Neurobiol; 2014 Mar; 114():58-83. PubMed ID: 24389580
[TBL] [Abstract][Full Text] [Related]
13. TLR-3 receptor activation protects the very immature brain from ischemic injury.
Shi H; Gabarin N; Hickey E; Askalan R
J Neuroinflammation; 2013 Aug; 10():104. PubMed ID: 23965176
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism.
Leung PY; Stevens SL; Packard AE; Lessov NS; Yang T; Conrad VK; van den Dungen NN; Simon RP; Stenzel-Poore MP
Stroke; 2012 May; 43(5):1383-9. PubMed ID: 22403050
[TBL] [Abstract][Full Text] [Related]
15. Can genes modify stroke outcome and by what mechanisms?
Simon RP; Meller R; Zhou A; Henshall D
Stroke; 2012 Jan; 43(1):286-91. PubMed ID: 22156698
[No Abstract] [Full Text] [Related]
16. Toll-like receptors in cerebral ischemic inflammatory injury.
Wang YC; Lin S; Yang QW
J Neuroinflammation; 2011 Oct; 8():134. PubMed ID: 21982558
[TBL] [Abstract][Full Text] [Related]
17. Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury.
Stevens SL; Leung PY; Vartanian KB; Gopalan B; Yang T; Simon RP; Stenzel-Poore MP
J Neurosci; 2011 Jun; 31(23):8456-63. PubMed ID: 21653850
[TBL] [Abstract][Full Text] [Related]
18. Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke.
Bahjat FR; Williams-Karnesky RL; Kohama SG; West GA; Doyle KP; Spector MD; Hobbs TR; Stenzel-Poore MP
J Cereb Blood Flow Metab; 2011 May; 31(5):1229-42. PubMed ID: 21285967
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic preconditioning: translating the promise.
Gidday JM
Transl Stroke Res; 2010 Jan; 1(1):19-30. PubMed ID: 21197121
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 4 in CNS pathologies.
Buchanan MM; Hutchinson M; Watkins LR; Yin H
J Neurochem; 2010 Jul; 114(1):13-27. PubMed ID: 20402965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
